3531 - 3540 of 8823 Results
Title
Year
-
OPENTitle: Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-SynucleinJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 185Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/63313Best OA location URL: https://www.jove.com/pdf/63313/analyzing-parkinson-s-disease-mouse-model-induced-adeno-associatedCitation Count: 2
-
OPENTitle: Unveiling the B cell receptor structureJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 819End Page: 820Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add8065Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11044948Citation Count: 12
-
OPENTitle: Toward preventing Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 818End Page: 819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add7162Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/113804Citation Count: 15
-
OPENTitle: Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 943End Page: 955Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13751Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13751Citation Count: 10
-
OPENTitle: GPNMB confers risk for Parkinson’s disease through interaction with α-synucleinJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: eabk0637End Page: eabk0637Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abk0637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9870036Citation Count: 141
-
RESTRICTEDTitle: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page: eabj2658End Page: eabj2658Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abj2658Citation Count: 239
- Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation2022OPENTitle: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and DifferentiationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 23Start Page: 3281End Page: 3290Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12316044Citation Count: 20
-
OPENTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 21
-
OPENTitle: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort StudyJournal Name: Diabetes CarePublisher: American Diabetes AssociationVol: 46Issue #: 2Start Page: 297End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2337/dc22-1705Best OA location URL: https://diabetesjournals.org/care/article-pdf/46/2/297/696578/dc221705.pdfCitation Count: 127
-
OPENTitle: Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication responseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 663Start Page: eadc9669End Page: eadc9669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adc9669Citation Count: 101